We are developing the first targeted therapy for Triple Negative Breast Cancer. It is the most aggressive type of breast cancer with no drugs currently available for its treatment and is an unmet need with a market size of $18.2 billion.
It’s easy to create a pitch using our online form. Your pitch can be in front of our 195,403 investors before you know it.
It’s free to join the world’s largest angel investment community. You’ll then have full access to this pitch (and all the others) and be able to connect with entrepreneurs.